In Historic Vote, FDA Backs Perjeta for Pre-surgical Breast Cancer Treatment
Ofatumumab Receives Breakthrough Therapy Designation for Earlier Use in CLL
Optimal Paclitaxel Schedule Identified for Early-Stage Breast Cancer
I-SPY Trials Seek Effective New Drug Combinations Using Adaptive Trial Design
Exploring New Ways to Broaden the Reach of Molecular Tumor Testing
Study Supports Feasibility of Routine Molecular Screening of NSCLC in Community Setting
